首页> 外文会议>Public Health International Conference >Correlation Between Aspartate Aminotransferase/Alanine Transferase Ratio (AST/ALT Ratio) and Stage of Liver Fibrosis in Patients with Chronic Hepatitis
【24h】

Correlation Between Aspartate Aminotransferase/Alanine Transferase Ratio (AST/ALT Ratio) and Stage of Liver Fibrosis in Patients with Chronic Hepatitis

机译:天冬氨酸氨基转移酶/丙氨酸转移酶比(AST / ALT比率)与慢性肝炎患者肝纤维化阶段的相关性

获取原文

摘要

Fibrosis is hallmark histologic event of chronic liver disease. Liver biopsy remains the gold standard for diagnosis and assessment of liver fibrosis in patients with chronic hepatitis. However, its invasive procedure and can have complication, not suitable for continous observation of liver fibrosis. The aspartate aminotransferase-alanin transferase ratio (AST/ALT ratio) has been used to evaluate prognosis of liver fibrosis and non-invasive proseduce for chronic hepatitis patients. To evaluate correlation between AST/ALT ratio and the stage of histologic liver fibrosis in chronic hepatitis patients. The study was restrospective design, where liver biopsy specimen has been collected from fourty chronic hepatitis patients during period Januari 2012 to December 2015. All histological slides were reviewed by two pathologists for evaluating histologic liver fibrosis by using Metavire score system. Patients characteristic were descriptifly analized, AST/ALT ratio and the stage of fibrosis were analized by using Spearman's correlation. The 40 patients were identified. The mean of age was 41 years, 70% patients were male. The number of patients with stage F1, F2, F3 and F4 of fibrosis respectively were 2 (5%), 16 (40%), 11 (27,5%), and 11(27,5%). The mean of AST/ALT ratio was 1,45 ± (SE mean 0,14). We found that there was statistically significant positive correlation between AST/ALT ratio with the stage of fibrosis (r = 0,843; p value< 0,01). AST/ALT ratio was correlated with the stage of fibrosis. It is recomended to used the ratio as prediction of pogressive liver functional impairment.
机译:纤维化是慢性肝病的标志性组织学事件。肝活检仍然是慢性肝炎患者肝纤维化诊断和评估的金标准。然而,其侵入性手术并且可以具有并发症,不适合肝纤维化的连续观察。 Asparate氨基转移酶 - 丙氨酸转移酶比(AST / Alt比)已被用于评估肝纤维化和慢性肝炎患者的非侵入性尿的预后。评价慢性肝炎患者AST / ALT比与组织学肝纤维化阶段的相关性。该研究是雷点设计,其中在2012年至2015年12月期间,从四十慢性肝炎患者收集了肝活检标本。通过使用美达瓦评分系统评估组织学肝纤维化的两位病理学家审查了所有组织学幻灯片。患者的特征描述了分析,通过使用Spearman的相关性进行AST / Alt比率和纤维化阶段。确定了40名患者。年龄的平均值为41岁,70%的患者是男性。纤维化阶段F1,F2,F3和F4的患者的数量分别为2(5%),16(40%),11(27,5%)和11(27,5%)。 AST / ALT比的平均值为1,45±(SE平均值0,14)。我们发现AST / ALT比与纤维化阶段之间存在统计学显着的正相关(r = 0,843; p值<0,01)。 AST / ALT比与纤维化阶段相关。推荐使用该比例作为批量生产肝功能障碍的预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号